These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1471 related articles for article (PubMed ID: 32249995)

  • 1. A comparison of robust Mendelian randomization methods using summary data.
    Slob EAW; Burgess S
    Genet Epidemiol; 2020 Jun; 44(4):313-329. PubMed ID: 32249995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.
    Bowden J; Davey Smith G; Burgess S
    Int J Epidemiol; 2015 Apr; 44(2):512-25. PubMed ID: 26050253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator.
    Bowden J; Davey Smith G; Haycock PC; Burgess S
    Genet Epidemiol; 2016 May; 40(4):304-14. PubMed ID: 27061298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modal-based estimation via heterogeneity-penalized weighting: model averaging for consistent and efficient estimation in Mendelian randomization when a plurality of candidate instruments are valid.
    Burgess S; Zuber V; Gkatzionis A; Foley CN
    Int J Epidemiol; 2018 Aug; 47(4):1242-1254. PubMed ID: 29846613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.
    Hartwig FP; Davey Smith G; Bowden J
    Int J Epidemiol; 2017 Dec; 46(6):1985-1998. PubMed ID: 29040600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constrained instruments and their application to Mendelian randomization with pleiotropy.
    Jiang L; Oualkacha K; Didelez V; Ciampi A; Rosa-Neto P; Benedet AL; Mathotaarachchi S; Richards JB; Greenwood CMT;
    Genet Epidemiol; 2019 Jun; 43(4):373-401. PubMed ID: 30635941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weak and pleiotropy robust sex-stratified Mendelian randomization in the one sample and two sample settings.
    Karageorgiou V; Tyrrell J; Mckinley TJ; Bowden J
    Genet Epidemiol; 2023 Mar; 47(2):135-151. PubMed ID: 36682072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy.
    Rees JMB; Wood AM; Burgess S
    Stat Med; 2017 Dec; 36(29):4705-4718. PubMed ID: 28960498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficient and robust approach to Mendelian randomization with measured pleiotropic effects in a high-dimensional setting.
    Grant AJ; Burgess S
    Biostatistics; 2022 Apr; 23(2):609-625. PubMed ID: 33155035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpreting findings from Mendelian randomization using the MR-Egger method.
    Burgess S; Thompson SG
    Eur J Epidemiol; 2017 May; 32(5):377-389. PubMed ID: 28527048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Powerful three-sample genome-wide design and robust statistical inference in summary-data Mendelian randomization.
    Zhao Q; Chen Y; Wang J; Small DS
    Int J Epidemiol; 2019 Oct; 48(5):1478-1492. PubMed ID: 31298269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A robust and efficient method for Mendelian randomization with hundreds of genetic variants.
    Burgess S; Foley CN; Allara E; Staley JR; Howson JMM
    Nat Commun; 2020 Jan; 11(1):376. PubMed ID: 31953392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weak-instrument robust tests in two-sample summary-data Mendelian randomization.
    Wang S; Kang H
    Biometrics; 2022 Dec; 78(4):1699-1713. PubMed ID: 34213007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropy robust methods for multivariable Mendelian randomization.
    Grant AJ; Burgess S
    Stat Med; 2021 Nov; 40(26):5813-5830. PubMed ID: 34342032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropy-robust Mendelian randomization.
    van Kippersluis H; Rietveld CA
    Int J Epidemiol; 2018 Aug; 47(4):1279-1288. PubMed ID: 28338774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian variable selection with a pleiotropic loss function in Mendelian randomization.
    Gkatzionis A; Burgess S; Conti DV; Newcombe PJ
    Stat Med; 2021 Oct; 40(23):5025-5045. PubMed ID: 34155684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mendelian randomization for causal inference accounting for pleiotropy and sample structure using genome-wide summary statistics.
    Hu X; Zhao J; Lin Z; Wang Y; Peng H; Zhao H; Wan X; Yang C
    Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2106858119. PubMed ID: 35787050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic.
    Bowden J; Del Greco M F; Minelli C; Davey Smith G; Sheehan NA; Thompson JR
    Int J Epidemiol; 2016 Dec; 45(6):1961-1974. PubMed ID: 27616674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-sample robust Bayesian Mendelian Randomization method accounting for linkage disequilibrium and idiosyncratic pleiotropy with applications to the COVID-19 outcomes.
    Wang A; Liu W; Liu Z
    Genet Epidemiol; 2022 Apr; 46(3-4):159-169. PubMed ID: 35192729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRCIP: a robust Mendelian randomization method accounting for correlated and idiosyncratic pleiotropy.
    Xu S; Fung WK; Liu Z
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33704372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.